Clinical Trials in Sanming, Fujian
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)
Hepatocellular Carcinoma (HCC)
Ruijin Hospital35 enrolled4 locationsNCT07331883
Recruiting
Phase 2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Muscle Invasive Bladder Cancer (MIBC)
Fujian Medical University Union Hospital25 enrolled12 locationsNCT07296705
Recruiting
Not Applicable
County Medical Community-based, Cardiovascular Risk Stratified Integrated Care Model: a Pragmatic Cluster Randomised Control Trial
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Peking University2,560 enrolled3 locationsNCT06302127
Recruiting
Effect of HPV Integration on Prognosis of Young Women With CIN2 in China
HPV InfectionHSIL, High Grade Squamous Intraepithelial LesionsCervical Intraepithelial Neoplasia+1 more
Fujian Maternity and Child Health Hospital300 enrolled20 locationsNCT05282095